Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dicloflex 75mg SR tablets (Actavis)
1001010C0BQANAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex 75mg SR tablets (Kent Pharm)
1001010C0BQAFAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex 75mg SR tablets (Teva)
1001010C0BQAEAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Almus)
1001010C0BQAMAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Kent Pharm)
1001010C0BQAHAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Teva)
1001010C0BQAGAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclotard 75mg modified-release tablets
1001010C0BZAAAL
|
Diclotard | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 25mg gastro-resistant tablets
1001010C0CCAAAD
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 50mg gastro-resistant tablets
1001010C0CCABAE
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 75mg SR tablets (Arun Pharm)
1001010C0CCACAL
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 75mg SR tablets (Mylan)
1001010C0CCAEAL
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol Retard 100mg tablets (Arun Pharm)
1001010C0CCADAF
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol Retard 100mg tablets (Mylan)
1001010C0CCAFAF
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclozip 25mg gastro-resistant tablets
1001010C0BIAAAD
|
Diclozip | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclozip 50mg gastro-resistant tablets
1001010C0BIABAE
|
Diclozip | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicobalt edetate 300mg/20ml solution for injection ampoules
1902070C0AAAAAA
|
Dicobalt edetate | Dicobalt edetate | Other Drugs and Preparations | No data available |
|
Diconal tablets
0407020H0BBAAAB
|
Diconal | Dipipanone hydrochloride | Central Nervous System | No data available |
|
Dicynene 250mg/2ml inj ampoules (Imported (India))
0211000D0BBADAA
|
Dicynene | Etamsylate | Cardiovascular System | No data available |
|
Dicynene 250mg/2ml solution for injection ampoules (Sanofi)
0211000D0BBACAA
|
Dicynene | Etamsylate | Cardiovascular System | No data available |
|
Dicynene 500 tablets
0211000D0BBABAF
|
Dicynene | Etamsylate | Cardiovascular System | No data available |
|
Didanosine 125mg gastro-resistant capsules
0503010N0AAAFAF
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 150mg dispersible chewable tablets sugar free
0503010N0AAADAD
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 200mg dispersible chewable tablets sugar free
0503010N0AAAEAE
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 200mg gastro-resistant capsules
0503010N0AAAGAG
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 250mg gastro-resistant capsules
0503010N0AAAHAH
|
Didanosine | Didanosine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.